NCT01772693View on ClinicalTrials.gov

ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

April 26, 2016

Study Completion Date

March 31, 2019

Conditions
Parkinson's Disease
Interventions
DEVICE

ExAblate Transcranial MRgFUS

ExAblate Transcranial MR Guided Focused Ultrasound

DEVICE

Sham ExAblate Transcranial MRgFUS

Sham ExAblate Transcranial MR Guided Focused Ultrasound

Trial Locations (2)

22908

University of Virginia, Charlottesville

98122

Swedish Medical Center, Seattle

Sponsors

Lead Sponsor

InSightec
All Listed Sponsors
lead

InSightec

INDUSTRY

NCT01772693 - ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's Disease | Biotech Hunter | Biotech Hunter